Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Kernicterus Treatment Market In 2029?
The market size of kernicterus treatment has witnessed slight expansion lately. The market is set to increase from $2.98 billion in 2024 to $3.03 billion in 2025, with a compound annual growth rate (CAGR) of 2.0%. Several factors have contributed to the market’s growth in the past, including enhancements in neonatal healthcare, greater awareness among medical professionals, government-supported maternal and child health initiatives, funding for research and clinical trials, as well as collaborations in medical studies.
The kernicterus treatment market size is expected to see steady growth in the next few years. It will grow to $3.3 billion in 2029 at a compound annual growth rate (CAGR) of 2.1%. The growth in the forecast period can be attributed to continuous medical education programs, global health policies and initiatives, patient advocacy and support groups, international collaboration in pediatric research, government funding for neonatal health. Major trends in the forecast period include advancements in neonatal jaundice monitoring technologies, introduction of phototherapy devices with enhanced features, development of bilirubin-reducing medications, focus on home-based phototherapy solutions, implementation of bilirubin nomograms and guidelines, integration of telehealth for remote monitoring.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13470&type=smp
Which Primay Drivers Are Accelerating Growth in the Kernicterus Treatment Market?
The surge in neonatal jaundice incidences is a significant factor contributing to the growth of the kernicterus treatment market. Essentially, neonatal jaundice, often referred to merely as jaundice in newborns, is a prevalent and usually benign condition that manifests as yellowing of a baby’s skin and eyes. Treatment for kernicterus, often employed in managing neonatal jaundice, is primarily targeted at symptom management and provision of supportive care. The process involves the removal of blood from the baby and substituting it with blood that has lower bilirubin levels, which in turn enhances the child’s quality of life. As per data released by the National Library of Medicine, a US-based biomedical library, in October 2023, around 60% of full-term babies and 80% of premature babies develop jaundice within the first week of birth, and about 10% of breastfed babies continue to display signs of jaundice at one month old. Therefore, the high occurrence of neonatal jaundice is set to boost the growth of the kernicterus treatment market.
Which Primary Segments of the Kernicterus Treatment Market Are Driving Growth and Industry Transformations?
The kernicterus treatmentmarket covered in this report is segmented –
1) By Treatment: Phototherapy; Intravenous Immunoglobulins (IVIG); Blood Transfusion; Medication; Other Treatments
2) By Symptoms: Jaundice; Unusual Eye Movements; Vomiting; Fever; Poor Feeding; Apnoea; Irritability; Seizures; Sleepiness; Other Symptoms
3) By Dosage: Injection; Solution; Other Dosages
4) By End-Users: Clinic; Hospital; Other End-Users
Subsegments:
1) By Phototherapy: Conventional Phototherapy; Fiberoptic Phototherapy; LED Phototherapy
2) By Intravenous Immunoglobulins (IVIG): Standard IVIG Therapy; High-Dose IVIG Therapy
3) By Blood Transfusion: Exchange Transfusion; Simple Transfusion
4) By Medication: Bilirubin-Lowering Agents; Antioxidants; Neuroprotective Agents
5) By Other Treatments: Supportive Care; Nutritional Support; Adjunct Therapies
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13470&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Kernicterus Treatment Market?# Market?
North America was the largest region in the kernicterus treatment market in 2024. The regions covered in the kernicterus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Kernicterus Treatment Industry Dynamics?
Leading establishments in the cornea treatment sector are emphasizing collaborations to enhance their reach and achieve an industry advantage. For example, in July 2024, the UCL Department of Medical Physics and Biomedical Engineering, an institution based in the UK, broadened its involvement in research and academics in the domains of medical physics and biomedical engineering. They joined forces with UCL Hospitals, also a UK-based hospital, and launched NeoSCB. This initiative is a mobile application that detects severe jaundice in newborns by evaluating pictures of the sclera (the eye’s white part), offering a non-intrusive testing method. This is particularly useful in areas with scarce resources where standard jaundice screening machinery is expensive. The application gauges the degree of yellowness in the sclera and associates this measurement with bilirubin concentration in the blood. It showed high precision, successfully diagnosing 74 out of 79 infants with severe jaundice. This effectiveness is similar to conventional methods like transcutaneous bilirubinometers, which estimate bilirubin through the skin.
View the full report here:
https://www.thebusinessresearchcompany.com/report/kernicterus-treatment-global-market-report
What Parameters Are Used to Define the Kernicterus Treatment Market?
Kernicterus is a rare neurological condition that can occur in newborns with severe jaundice, a condition characterized by high levels of bilirubin in the blood. Kernicterus treatment refers to the medical interventions, therapies, and supportive care provided to individuals, typically infants and children. This treatment aims to address kernicterus’s symptoms, complications, and long-term effects and improve the quality of life for affected individuals.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13470
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model